Abstract
With the aim to overcome the lack of potent and selective Hyaluronidases (Hyals) inhibitors, we have tested new 1, 3 and 5 substituted indole derivatives for the inhibition of bovine testicular hyaluronidases (BTH) in a stains-all assay at pH 7 and in a Morgan-Elson assay at pH 3.5. Most of the compounds are found as activator at pH 3.5. Although amine compounds 17 and 18 did not show inhibition of BTH at pH 7, they reacted as most potent activators of BTH at pH 3.5. On the other hand, some of the imine compounds reacted as the inhibitors at pH 7 and compound 25 was found as the most potent inhibitor.
Keywords: Hyaluronidase, Indole derivatives, Inhibition, Morgan-Elson assay, Stains all assay, Structure-activity, glycosaminoglycanes, HA fragments, extracellular matrix, opthalmology, lanostanoids, Vilsmeir formylation reaction, Schiff bases, Stains-all Assay
Letters in Drug Design & Discovery
Title: Structure-Activity Evaluation of N-benzyl-5-substituted Indole-3-imine Derivatives and their Amine Congeners as Bovine Testicular Hyaluronidase (BTH) Inhibitor
Volume: 8 Issue: 8
Author(s): S. Olgen, A. Kaessler, Z. Kilic Kurt and J. Jose
Affiliation:
Keywords: Hyaluronidase, Indole derivatives, Inhibition, Morgan-Elson assay, Stains all assay, Structure-activity, glycosaminoglycanes, HA fragments, extracellular matrix, opthalmology, lanostanoids, Vilsmeir formylation reaction, Schiff bases, Stains-all Assay
Abstract: With the aim to overcome the lack of potent and selective Hyaluronidases (Hyals) inhibitors, we have tested new 1, 3 and 5 substituted indole derivatives for the inhibition of bovine testicular hyaluronidases (BTH) in a stains-all assay at pH 7 and in a Morgan-Elson assay at pH 3.5. Most of the compounds are found as activator at pH 3.5. Although amine compounds 17 and 18 did not show inhibition of BTH at pH 7, they reacted as most potent activators of BTH at pH 3.5. On the other hand, some of the imine compounds reacted as the inhibitors at pH 7 and compound 25 was found as the most potent inhibitor.
Export Options
About this article
Cite this article as:
Olgen S., Kaessler A., Kurt Z. Kilic and Jose J., Structure-Activity Evaluation of N-benzyl-5-substituted Indole-3-imine Derivatives and their Amine Congeners as Bovine Testicular Hyaluronidase (BTH) Inhibitor, Letters in Drug Design & Discovery 2011; 8 (8) . https://dx.doi.org/10.2174/157018011796576079
DOI https://dx.doi.org/10.2174/157018011796576079 |
Print ISSN 1570-1808 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-628X |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Targeting Cancer Cells by an Oxidant-Based Therapy
Current Molecular Pharmacology Potential Anticancer Properties of Bisphosphonates: Insights From Preclinical Studies
Anti-Cancer Agents in Medicinal Chemistry Mechanism-Based Treatment in Chronic Neuropathic Pain: The Role of Antidepressants
Current Pharmaceutical Design The Role of B-Lymphocyte Stimulator in Neuroendocrine Tumors: Correlation with Tumor Differentiation, Disease status and the Presence of Metastases
Immunology, Endocrine & Metabolic Agents in Medicinal Chemistry (Discontinued) Hepatocellular Carcinoma Detection by Gallium Scan and Subsequent Treatment by Gallium Maltolate: Rationale and Case Study
Anti-Cancer Agents in Medicinal Chemistry Combinations of Plant Polyphenols & Anti-Cancer Molecules: A Novel Treatment Strategy for Cancer Chemotherapy
Anti-Cancer Agents in Medicinal Chemistry Application of Bacterial Nanocellulose in Cancer Drug Delivery: A Review
Current Pharmaceutical Design Inhibition of Aurora A Kinase by Alisertib Induces Autophagy and Cell Cycle Arrest and Increases Chemosensitivity in Human Hepatocellular Carcinoma HepG2 Cells
Current Cancer Drug Targets Use of Insulin and Insulin Analogs and Risk of Cancer — Systematic Review and Meta-Analysis of Observational Studies
Current Drug Safety Non-Viral Gene Delivery to the Lungs
Current Gene Therapy Targeting Metallothionein for Prognosis and Treatment of Breast Cancer
Recent Patents on Anti-Cancer Drug Discovery Oxaliplatin-mediated Inhibition of Survivin Increases Sensitivity of Head and Neck Squamous Cell Carcinoma Cell Lines to Paclitaxel
Current Cancer Drug Targets Molecular Mechanisms Underlying St. Johns Wort Drug Interactions
Current Drug Metabolism Fanconi Anemia Proteins, DNA Interstrand Crosslink Repair Pathways, and Cancer Therapy
Current Cancer Drug Targets Exploiting Internal Ribosome Entry Sites in Gene Therapy Vector Design
Current Gene Therapy Neoadjuvant Chemotherapy Before Radical Cystectomy: Why We Must Adhere?
Current Drug Targets Proteomic Approaches for the Study of Transgelins as Tumor-associated Proteins and Potential Biomarkers
Current Proteomics Antimetastatic Activities and Mechanisms of Bisdioxopiperazine Compounds
Anti-Cancer Agents in Medicinal Chemistry Molecular Mechanisms of Anti-cancer Activities of β-elemene: Targeting Hallmarks of Cancer
Anti-Cancer Agents in Medicinal Chemistry Targeted Drug Delivery System for Platinum-based Anticancer Drugs
Mini-Reviews in Medicinal Chemistry